Literature DB >> 22394455

Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry.

Karl B Scheidweiler1, Diaa M Shakleya, Marilyn A Huestis.   

Abstract

BACKGROUND: Mecamylamine is a nicotine antagonist under investigation in combination with nicotine replacement for smoking treatment.
METHODS: A simple, rapid and reliable liquid chromatography tandem mass spectrometry (LCMSMS) method was developed and validated for quantifying nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine. Chromatography was performed on a Synergi PolarRP column with a gradient of 0.1% formic acid and 0.1% formic acid in acetonitrile at 0.25 ml/min with an 8-min total runtime. Analytes were monitored by positive mode electrospray ionization and multiple reaction monitoring mass spectrometry.
RESULTS: Linear dynamic ranges were 1-500 ng/ml for nicotine and norcotinine, 0.5-500 ng/ml for trans-3'-hydroxycotinine, 0.2-500 ng/ml for cotinine, and 0.1-100 ng/ml for mecamylamine; correlation coefficients were consistently greater than 0.99, and all calibrator concentrations were within 20% of target. Extensive endogenous and exogenous interferences were evaluated. At 3 concentrations spanning the linear dynamic range of the assay, mean extraction efficiencies from urine were 55.1-109.1% with analytical recovery (bias) 82.0-118.7% and total imprecision of 0.7-9.1%. Analytes were stable for 24h at room temperature, 72 h at 4 °C, 72 h in autosampler at 15 °C and after three freeze/thaw cycles.
CONCLUSION: This method is useful for monitoring mecamylamine, nicotine and nicotine metabolites in smoking cessation and other clinical nicotine research. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22394455      PMCID: PMC3319642          DOI: 10.1016/j.cca.2012.02.017

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  30 in total

1.  Analysis of nicotine, 3-hydroxycotinine, cotinine, and caffeine in urine of passive smokers by HPLC-tandem mass spectrometry.

Authors:  T Tuomi; T Johnsson; K Reijula
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

2.  Simultaneous determination of mecamylamine, nicotine, and cotinine in plasma by gas chromatography-mass spectrometry.

Authors:  P Jacob; S Wu; L Yu; N L Benowitz
Journal:  J Pharm Biomed Anal       Date:  2000-09       Impact factor: 3.935

3.  Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players.

Authors:  François Marclay; Martial Saugy
Journal:  J Chromatogr A       Date:  2010-10-25       Impact factor: 4.759

4.  Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

Authors:  Peyton Jacob; Lisa Yu; Minjiang Duan; Lita Ramos; Olivia Yturralde; Neal L Benowitz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-21       Impact factor: 3.205

Review 5.  Mecamylamine (a nicotine antagonist) for smoking cessation.

Authors:  T Lancaster; L F Stead
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry.

Authors:  Michael Meger; Irmtrud Meger-Kossien; Annette Schuler-Metz; Dinamis Janket; Gerhard Scherer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-10-05       Impact factor: 3.205

7.  A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone.

Authors:  Raniah Q Gabr; Marwa E Elsherbiny; Vishwa Somayaji; P Timothy Pollak; Dion R Brocks
Journal:  Biomed Chromatogr       Date:  2011-02-10       Impact factor: 1.902

8.  Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation.

Authors:  D Debruyne; F Sobrio; A Hinschberger; R Camsonne; A Coquerel; L Barré
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

9.  Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level.

Authors:  C S Pomerleau; O F Pomerleau; M J Majchrzak
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction.

Authors:  Chiung-Wen Hu; Yan-Zin Chang; Hsiao-Wen Wang; Mu-Rong Chao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-08-16       Impact factor: 4.254

View more
  8 in total

Review 1.  The chemical components of electronic cigarette cartridges and refill fluids: review of analytical methods.

Authors:  Marco Famele; Carolina Ferranti; Carmelo Abenavoli; Luca Palleschi; Rosanna Mancinelli; Rosa Draisci
Journal:  Nicotine Tob Res       Date:  2014-09-25       Impact factor: 4.244

2.  Development of a Cigarette Tobacco Filler Standard Reference Material.

Authors:  Lane C Sander; Jeanita S Pritchett; Yasmine C Daniels; Laura J Wood; Brian E Lang; Stephen A Wise; James H Yen; Tricia L Johnson; Matthew J Walters; Tracy Phillips; Matthew R Holman; Grace E Lee; Joseph G Lisko; Brian Lane; Liza Valentin-Blasini; Clifford Watson
Journal:  Anal Chem       Date:  2017-09-20       Impact factor: 6.986

3.  Validated single urinary assay designed for exposomic multi-class biomarkers of common environmental exposures.

Authors:  Ravikumar Jagani; Divya Pulivarthi; Dhavalkumar Patel; Rosalind J Wright; Robert O Wright; Manish Arora; Mary S Wolff; Syam S Andra
Journal:  Anal Bioanal Chem       Date:  2022-06-27       Impact factor: 4.478

4.  A high-throughput robotic sample preparation system and HPLC-MS/MS for measuring urinary anatabine, anabasine, nicotine and major nicotine metabolites.

Authors:  Binnian Wei; June Feng; Imran J Rehmani; Sharyn Miller; James E McGuffey; Benjamin C Blount; Lanqing Wang
Journal:  Clin Chim Acta       Date:  2014-06-23       Impact factor: 3.786

5.  Simultaneous determination of cotinine and trans-3-hydroxycotinine in urine by automated solid-phase extraction using gas chromatography-mass spectrometry.

Authors:  Fouad Chiadmi; Joël Schlatter
Journal:  Biomed Chromatogr       Date:  2014-02-24       Impact factor: 1.902

6.  Recent Advances in Mass Spectrometry for the Identification of Neuro-chemicals and their Metabolites in Biofluids.

Authors:  Suresh Kumar Kailasa; Hui-Fen Wu
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

7.  Application of HPLC-QQQ-MS/MS and New RP-HPLC-DAD System Utilizing the Chaotropic Effect for Determination of Nicotine and Its Major Metabolites Cotinine, and trans-3'-Hydroxycotinine in Human Plasma Samples.

Authors:  Jacek Baj; Wojciech Flieger; Dominika Przygodzka; Grzegorz Buszewicz; Grzegorz Teresiński; Magdalena Pizoń; Ryszard Maciejewski; Jolanta Flieger
Journal:  Molecules       Date:  2022-01-20       Impact factor: 4.411

8.  A convenient UHPLC-MS/MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse.

Authors:  Mohammad A Kaisar; Raja Reddy Kallem; Ravi K Sajja; Ali Ehsan Sifat; Luca Cucullo
Journal:  BMC Neurosci       Date:  2017-10-11       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.